Home  >  Health Check  >  Gene therapy for sickle cell disease
Health Check
Gene therapy for sickle cell disease
Health Check
Dec 9, 2020

Are genetic therapies for sickle cell disease beginning to come of age? Claudia Hammond talks to David Williams and Erica Esrick of Boston Children’s Hospital about their promising results with a gene therapy for the disease in a pilot trial involving six young patients. Their report appears in the latest edition of the New England Journal of Medicine alongside encouraging results of a CRISPR gene editing therapy for sickle cell disease. Both approaches target the same gene – the result of which is to make bone marrow cells to produce foetal haemoglobin to compensate for people’s faulty adult haemoglobin.

BBC Global health correspondent Naomi Grimley has a coronavirus global round up for us, and we report on the discovery of a pair of salivary glands new to medical science – the first new set of organs to be discovered for centuries. Dutch researchers detected them with a sophisticated form of body scanning, hiding where the back of the nasal cavity meets the top of the throat. It’s an anatomical revelation which may have implications for kinder radiotherapy for head and neck cancer.

Claudia’s studio guest is Tabitha Mwangi, who is a lecturer in public health at Anglia Ruskin University and has also been a malaria researcher in Kenya. Tabitha talks about the great benefits of giving children four months of malaria prophylaxis tablets during the rainy season in West and Central sub-Sahelian Africa. A study involving millions of children and tens of thousands of health workers halved the number of children dying from malaria. Tabitha also tells Claudia about a simple strategy for improving the success rate in getting people onto TB treatment quickly, and whether schemes in low income countries to encourage mothers to grow their own vegetables to improve their children’s nutrition actually work.

Presenter: Claudia Hammond Producer: Andrew Luck-Baker

(Picture: Dr. Erica Esrick and Manny Johnson, the first patient to participate in the Boston Children’s Hospital sickle cell disease clinical trial. Credit: Boston’s Children’s Hospital.)

More Episodes


Mar 25, 2026
Antimicrobial resistance in conflict zones

For the last few weeks, the news has been dominated by the situation in the Middle East. Joining Claudia Hammond is BBC Health Correspondent James Gallagher who speaks with Dr Antoine Abou Fayad, a microbiologist and medicinal chemist based in Beirut, Lebanon. He reveals that war, just like the ongoing conflict in the Middle East, provides the perfect storm to accelerate the spread of multidrug-resistant infections. And nobody is safe.

Following the recent meningitis B outbreak in the UK which has killed two people and led to the rollout of vaccines and preventative antibiotics, Claudia and James discuss how meningitis outbreaks are dealt with in the ‘meningitis belt’ - an area stretching across 26 sub-Saharan African countries and talk about a new vaccine aiming to stop deadly meningitis epidemics which has been confirmed to be safe following analysis of vaccination campaigns in Nigeria and Niger.

And India's snakebite crisis is killing near sixty thousand people every year, about six people every hour. Journalist Chhavi Sachdev joins us to discuss the progress of India’s National Action Plan to tackle snakebite envenoming which launched two years ago. Also, what time of day do you exercise? Well, a new study using Fitbit-derived heart rate data has found that people who regularly exercised early in the morning were significantly less likely to have coronary artery disease, high blood pressure, Type 2 diabetes or obesity compared with people who exercised later in the day.

Presenter: Claudia Hammond Producer: Jonathan Blackwell


26min 28sec

Mar 18, 2026
Does your home country impact your cancer risk?

North Korean defectors and lifelong South Korean residents have significantly different cancer rates, despite their genetic similarities; new research finds. Presenter Laura Foster unpacks this study, explaining what it tells us about how upbringing and environment contribute to different cancer rates, and how migration can change these risks.

A new study has found GLP-1s – drugs typically used to treat diabetes and obesity – could have an unexpected benefit for patients dealing with substance abuse disorders. Laura speaks with Ziyad Al-Aly, a clinical epidemiologist and Veterans Affairs physician at Washington University in St Louis to understand what this could mean for treating drug and alcohol addictions, and what questions still need answers before this treatment can be rolled out.

Last weekend, Kenya’s National Environment Management Authority rolled out new waste management rules to better dispose of products containing plastic, but the new laws are expected to increase the price of sanitary pads by 20%. Global health reporter based in Nairobi, Dorcas Wangira joins Laura to unpack what these policies mean for the accessibility of sanitary products, and what alternative solutions are needed to balance access with environmental impact. They also discuss how a drug to treat Parkinson’s disease can be made from waste plastic bottles using a pioneering method.

And Jane Chambers reports from Peru about the growing prevalence of anaemia, speaking to local healthcare workers about what steps families can be taken to help their children recover.

Presenter: Laura Foster Producers: Jonathan Blackwell and Georgia Christie


26min 28sec

Gene therapy for sickle cell disease

--:--
--:--